Skip to content

Effectiveness of occupational therapy in Parkinson*s disease: a nationwide, randomized controlled trial.

Effectiveness of occupational therapy in Parkinson*s disease: a nationwide, randomized controlled trial. - The OTiP trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON33392
Enrollment
250
Registered
2009-08-25
Start date
2009-10-02
Completion date
Unknown
Last updated
2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parkinson's Parkinson's Disease

Interventions

Patients in the experimental group will receive 10 weeks (max 16 sessions) of occupational therapy according to a treatment protocol, which is based on the evidence based guideline *Occupational The

Sponsors

Universitair Medisch Centrum Sint Radboud
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria patients 1 Idiopathic Parkinson's Disease according to accepted criteria. 2 Need for assistance in daily activities 3 Home dwelling;Inclusion criteria caregivers 1 Providing informal support minimal two times a week to a patient who participates in the study 2 Available to take part in the intervention.

Exclusion criteria

Exclusion criteria: 1 Co morbidity with symptoms that precludes active partcipation in the intervention (e.g psychosis, severe cardiac failure). Or limitations in activities are dominated by the co morbid condition rather than by Parkinson*s Disease. 2 Current participation in other allied health research (IMPACT, PARKFIT, ERGODIM) 3 Having received occupational therapy in the last 12 months

Design outcomes

Secondary

MeasureTime frame
Secondary outcomes/endpoints are: self perceived performance in daily activities (patient and caregiver), participation and autonomy (patient), quality of life (patient and caregiver), and objective burden of care (caregiver).

Primary

MeasureTime frame
The primary outcome/endpoint for the patient is the quality and level of independence in daily functioning, assessed with the Assessment of Motor and Process Skills (AMPS) and the Amsterdam Medical Centre Linear Disability Score (ALDS). The primary outcome/ endpoint for the caregivers is their self perceived burden of care as assessed with the Zarit Burden Inventory (ZBI). The primary analysis will be the changes between baseline and 3 months after start of the intervention.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)